Proshares UltraPro Nasdaq Biotechnology (UBIO) Slipped -6.39% or -2.37 To Price $34.73 On Wednesday

Proshares UltraPro Nasdaq Biotechnology (UBIO) slipped -6.39% or -2.37 to $34.73. It is nearly 46669 shares traded, which is 167.52% compare to the average total volume 27859. The market cap of UBIO is $27.78 million. The year to date change is -14.06%. The 52 week price range is from $25.8 to $46.35. Price of UBIO have changed -14.52% during last week. It have changed -7.44% over last month, -6.83% over last 3 months, 31.93% over last 6 months and -8.78% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for UBIO is 40.70. It is 17.19% above current price. The 200-day Moving Averages for UBIO is 36.16. It is 4.12% above current price. The 52-week High is 46.35. It is 33.46% from the current price. The 52-week Low is 25.8. It is -25.71% from current price.

There are some statistics of UBIO. It is has market cap $27.78 million. The share outstanding is 849915. The average volume is 27859. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of UBIO is 4.66%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of UBIO is -3.41%.


Share this post